Well if we are going to over analyze every word spoken, let
Well if we are going to over analyze every word spoken, let me give it a go...
The board started questioning NP and Kellys leadership a little... Probably had some very heated discussions behind closed doors (which I might remind everyone this forum is definitely not).
The board might have even said we want you to hire xyz.... So Nader said alright heres your Manboobs...
After several months Nader and Kelly went to the board and said "Manboobs needs to go, and here is why... Do you still question us or support us fully again"?
The board said 'sorry for doubting you, do whatever you need to get us to where we want to be'.
Or maybe the board said 'continue to do whatever the FDA ask' so nader and kelly did, until they proved to the board the FDA is a complete joke that only cares about jabbing people with vaccines (now little kids) and not healing the sick... The board said OK, we do not doubt you now, do what you need to.
See how this works???? Who knows what happened, and why should we care? We are in good shape.
I personally would like to thank the FDA, Big Pharma, the shorts, and an over giddy Nader for giving me so many opportunities to accumulate shares at dirt cheap (anything below $5) prices. Many of you that have been complaining that we are at xxx price when we should be a few bucks higher are going to wish you would have been buying as many shares as possible with all the opportunities that were available... Instead of spending time bitching and complaining about Nader I was spending those hours making extra money so I could buy more shares before it hits $10+ with one EUA
GLTA longs
15
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A Bra Revolution or Just Another Launch? I'll admit it, lingerie isn't the usual breakfast discussion for me, but Vanity Fair Lingerie's move with their new Flawlessly Smooth™ Bra piqued my interest. Announced in Bowling Green, Kentucky, on November 2, 2026, and set against the lavish backdrop of an upcoming New York City event cohosted by Cosmopolitan, it's less about...
Continue Reading
A Rising Star in the Banking World You don't see a lot of folks these days making waves in the banking sector quite like Kirk Goehring has. And it's a decent feat, earning a nod from the American Bankers Association (ABA) as one of their 2026 Emerging Leader Awards recipients. For those of you wondering if this is just another hollow accolade, think again. The ABA doesn't...
Continue Reading
Who would've thought your morning coffee ritual could be in cahoots with a silent tooth villain? Well, Dr. Kari Sakurai at Pacific View Smile Center slices through the noise with some fascinating insights on early tooth decay, spun out in an article by HelloNation. You see, Dr. Sakurai, like a dental James Bond, is fighting the good fight against cavities before they even...
Continue Reading
Novartis Drops BioArctic Like a Hot Potato Well, folks, it looks like Novartis has decided to pack up its bags and hightail it out of its collaboration with BioArctic AB. This ain't just any small piece of news—it's got ramifications that have folks in the biotech and healthcare sector scratching their heads and, probably, feeling a mixture of apprehension and...
Continue Reading
Corporate Deals Under the Microscope: What's at Stake? The headlines are shouting: ADT, Instacart, and Ultralife are all embroiled in merger activities that might not exactly be what shareholders signed up for. On the surface, you've got big names like DoorDash stepping up to snag some of these firms, but the question here is whether the deals are truly fair—or if...
Continue Reading
Akash's Bold Move: Embracing Solana Never thought I'd see a day where Akash Network would toss its hat in with Solana. An unexpected power play, but not without reason. By moving their decentralized compute marketplace to Solana, they aim to leverage one of the slickest blockchain ecosystems around. It's like swapping a four-cylinder for a V8 – there's a potential for...
Continue Reading
Leidos Sets Sights on Boosting U.S. Missile Production There's big news out of Reston, Virginia, that should make investors sit up and take notice. Leidos (NYSE: LDOS) is revving up the supply chain engines to churn out thousands of long-range cruise missiles, specifically the new Low-Cost Containerized Missile (LCCM) and the combat-time-tested AGM-190A Havoc Spear...
Continue Reading
Trouble Surfacing for D-Wave Quantum Investors It's another day, another dollar slipping out of an investor's pocket. Welcome to the circus. Today's main act? D-Wave Quantum, Inc., sporting a 9.51% drop in stock value. Now, those holding NASDAQ: QBTS shares during that class period between late February and August of 2026 might want to listen up. The lawyers over at...
Continue Reading
Diving Deep into CNTE's Latest Achievement The energy storage game has a new major player, and it's none other than Contemporary Nebula Technology Energy Co., Ltd. (CNTE). November 3, 2026, wasn't just another autumn day in London—it was a stage for CNTE to mark its entry onto BloombergNEF's Q4 2026 Tier 1 Energy Storage Manufacturers List. This ain't just another...
Continue Reading
Singapore's Bold Step into Precision Medicine When it comes to revolutionizing healthcare, Singapore isn't content to sit on the sidelines. They've just thrown a serious hat into the ring with the SG-INSIGHT study, a cornerstone of their National Precision Medicine programme. And Illumina, Inc. (NASDAQ:ILMN) is right there in it, gearing up to sequence the genomes of...
Continue Reading
Top 5 Most Recently Viewed Articles
Comgest Expands U.S. Investor Relations Team with New Hires Comgest, a prominent global equity asset manager dedicated to long-term quality growth, has recently announced an exciting expansion of its U.S. Investor Relations team. This initiative is led by James DuPont, the Investor Relations Manager at Comgest, who welcomes two seasoned professionals to the organization....
Continue Reading
G42 Appoints Ali Dalloul as Group Chief Strategy Officer G42, a leading AI and cloud computing company, has made a significant move by appointing Ali Dalloul as its Group Chief Strategy Officer. This decision comes as part of G42's strategy to enhance its leadership in the AI sector. Dalloul, a seasoned American technology executive, brings a wealth of experience to the...
Continue Reading
Transforming Government Operations with Advanced AI Solutions REI Systems, a trailblazer in technology solutions for federal agencies, has just announced a groundbreaking advancement in artificial intelligence (AI) that promises to significantly enhance governmental efficiency. Their new suite of AI solutions, centered around the innovative approach titled 'Mindful AI,...
Continue Reading
Elevating Research with One Helix One Helix emerges as a landmark project in life sciences, representing a new era of innovation and sustainable architecture. Located within a prominent university medical center, this facility is not just a building; it is a commitment to fostering scientific advancements. Completely leased to AstraZeneca, One Helix is designed to elevate...
Continue Reading
Okeanis Eco Tankers Announce Director Changes In recent corporate news, Okeanis Eco Tankers Corp. (NYSE:ECO / OSE:OET) has announced significant shifts in its board of directors. Veteran directors Robert Knapp and Joshua Nemser have chosen to resign, effective immediately. This decision came as a surprise, but the company reassures stakeholders that the resignations were...
Continue Reading